These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 20209595

  • 21. Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol.
    Fix OK, Bass NM, De Marco T, Merriman RB.
    Liver Transpl; 2007 Jun; 13(6):875-85. PubMed ID: 17539008
    [Abstract] [Full Text] [Related]

  • 22. Effects of nebulised iloprost on pulmonary function and gas exchange in severe pulmonary hypertension.
    Reichenberger F, Mainwood A, Doughty N, Fineberg A, Morrell NW, Pepke-Zaba J.
    Respir Med; 2007 Feb; 101(2):217-22. PubMed ID: 16831539
    [Abstract] [Full Text] [Related]

  • 23. Iloprost improves gas exchange and exercise tolerance in patients with pulmonary hypertension and chronic obstructive pulmonary disease.
    Dernaika TA, Beavin M, Kinasewitz GT.
    Respiration; 2010 Feb; 79(5):377-82. PubMed ID: 19786728
    [Abstract] [Full Text] [Related]

  • 24. Inhaled nitric oxide reduces pulmonary artery pressures in portopulmonary hypertension.
    Findlay JY, Harrison BA, Plevak DJ, Krowka MJ.
    Liver Transpl Surg; 1999 Sep; 5(5):381-7. PubMed ID: 10477839
    [Abstract] [Full Text] [Related]

  • 25. Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studies.
    Voswinckel R, Enke B, Reichenberger F, Kohstall M, Kreckel A, Krick S, Gall H, Gessler T, Schmehl T, Ghofrani HA, Schermuly RT, Grimminger F, Rubin LJ, Seeger W, Olschewski H.
    J Am Coll Cardiol; 2006 Oct 17; 48(8):1672-81. PubMed ID: 17045906
    [Abstract] [Full Text] [Related]

  • 26. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
    Schermuly RT, Kreisselmeier KP, Ghofrani HA, Samidurai A, Pullamsetti S, Weissmann N, Schudt C, Ermert L, Seeger W, Grimminger F.
    Circ Res; 2004 Apr 30; 94(8):1101-8. PubMed ID: 15031263
    [Abstract] [Full Text] [Related]

  • 27. Experience with inhaled iloprost and bosentan in portopulmonary hypertension.
    Hoeper MM, Seyfarth HJ, Hoeffken G, Wirtz H, Spiekerkoetter E, Pletz MW, Welte T, Halank M.
    Eur Respir J; 2007 Dec 30; 30(6):1096-102. PubMed ID: 17652314
    [Abstract] [Full Text] [Related]

  • 28. A comparison of the acute hemodynamic effects of inhaled nitroglycerin and iloprost in patients with pulmonary hypertension undergoing mitral valve surgery.
    Yurtseven N, Karaca P, Uysal G, Ozkul V, Cimen S, Tuygun AK, Yuksek A, Canik S.
    Ann Thorac Cardiovasc Surg; 2006 Oct 30; 12(5):319-23. PubMed ID: 17095973
    [Abstract] [Full Text] [Related]

  • 29. Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension.
    Opitz CF, Wensel R, Winkler J, Halank M, Bruch L, Kleber FX, Höffken G, Anker SD, Negassa A, Felix SB, Hetzer R, Ewert R.
    Eur Heart J; 2005 Sep 30; 26(18):1895-902. PubMed ID: 15888496
    [Abstract] [Full Text] [Related]

  • 30. Inhaled aerosolized iloprost in the evaluation of heart transplant candidates--experiences with 45 cases.
    Sablotzki A, Hentschel T, Hofmann S, Simm A, Mühling J, Czeslick E.
    J Clin Anesth; 2006 Mar 30; 18(2):108-13. PubMed ID: 16563327
    [Abstract] [Full Text] [Related]

  • 31. Comparison of the usage of intravenous iloprost and nitroglycerin for pulmonary hypertension during valvular heart surgery.
    Baysal A, Bilsel S, Bulbul OG, Kayacioglu I, Idiz M, Yekeler I.
    Heart Surg Forum; 2006 Mar 30; 9(1):E536-42. PubMed ID: 16387672
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost.
    Wolff B, Lodziewski S, Bollmann T, Opitz CF, Ewert R.
    Am Heart J; 2007 Jun 30; 153(6):1088.e1-7. PubMed ID: 17540215
    [Abstract] [Full Text] [Related]

  • 35. Use of aerosolized inhaled iloprost in the treatment of portopulmonary hypertension.
    Halank M, Marx C, Miehlke S, Hoeffken G.
    J Gastroenterol; 2004 Dec 30; 39(12):1222-3. PubMed ID: 15622492
    [No Abstract] [Full Text] [Related]

  • 36. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG, Albillos A, Bañares R, Turnes J, González R, García-Pagán JC, Bosch J.
    Gastroenterology; 2009 May 30; 136(5):1651-8. PubMed ID: 19208350
    [Abstract] [Full Text] [Related]

  • 37. Long-term inhaled iloprost use in children with pulmonary arterial hypertension.
    Alehan D, Yıldırım I, Sahin M, Ozkutlu S, Ozer S, Karagöz T.
    Cardiol Young; 2012 Aug 30; 22(4):396-403. PubMed ID: 22067137
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension.
    Braun S, Schrötter H, Schmeisser A, Strasser RH.
    Int J Cardiol; 2007 Jan 31; 115(1):67-72. PubMed ID: 16797747
    [Abstract] [Full Text] [Related]

  • 40. Assessment of acute pulmonary vascular reactivity in portopulmonary hypertension.
    Ricci GL, Melgosa MT, Burgos F, Valera JL, Pizarro S, Roca J, Rodriguez-Roisin R, Barberà JA.
    Liver Transpl; 2007 Nov 31; 13(11):1506-14. PubMed ID: 17969197
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.